L'inactivation des virus dans les fractions plasmatiques à usage thérapeutique.

Translated title of the contribution: Virus inactivation in plasma fractions for therapeutic use

T. Burnouf, L. Martinache, M. Goudemand

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Methods to inactivate (or eliminate) viruses must be developed to ensure the safety of blood plasma fractions. For that purpose, dry or liquid heat treatment, solvent/detergent mixtures, beta-propiolactone/ultraviolet treatment, and chromatographic methods are the main procedures in use to date.

Original languageFrench
Pages (from-to)93-96
Number of pages4
JournalNouvelle revue francaise d"hematologie
Volume29
Issue number1
Publication statusPublished - 1987
Externally publishedYes

Fingerprint

Virus Inactivation
Therapeutic Uses
Propiolactone
Detergents
Hot Temperature
Viruses
Safety

ASJC Scopus subject areas

  • Medicine(all)

Cite this

L'inactivation des virus dans les fractions plasmatiques à usage thérapeutique. / Burnouf, T.; Martinache, L.; Goudemand, M.

In: Nouvelle revue francaise d"hematologie, Vol. 29, No. 1, 1987, p. 93-96.

Research output: Contribution to journalArticle

@article{a42853094ed1471cb01414958a419479,
title = "L'inactivation des virus dans les fractions plasmatiques {\`a} usage th{\'e}rapeutique.",
abstract = "Methods to inactivate (or eliminate) viruses must be developed to ensure the safety of blood plasma fractions. For that purpose, dry or liquid heat treatment, solvent/detergent mixtures, beta-propiolactone/ultraviolet treatment, and chromatographic methods are the main procedures in use to date.",
author = "T. Burnouf and L. Martinache and M. Goudemand",
year = "1987",
language = "法语",
volume = "29",
pages = "93--96",
journal = "Nouvelle revue francaise d{"}hematologie",
number = "1",

}

TY - JOUR

T1 - L'inactivation des virus dans les fractions plasmatiques à usage thérapeutique.

AU - Burnouf, T.

AU - Martinache, L.

AU - Goudemand, M.

PY - 1987

Y1 - 1987

N2 - Methods to inactivate (or eliminate) viruses must be developed to ensure the safety of blood plasma fractions. For that purpose, dry or liquid heat treatment, solvent/detergent mixtures, beta-propiolactone/ultraviolet treatment, and chromatographic methods are the main procedures in use to date.

AB - Methods to inactivate (or eliminate) viruses must be developed to ensure the safety of blood plasma fractions. For that purpose, dry or liquid heat treatment, solvent/detergent mixtures, beta-propiolactone/ultraviolet treatment, and chromatographic methods are the main procedures in use to date.

UR - http://www.scopus.com/inward/record.url?scp=0023065139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023065139&partnerID=8YFLogxK

M3 - 文章

C2 - 3588282

AN - SCOPUS:0023065139

VL - 29

SP - 93

EP - 96

JO - Nouvelle revue francaise d"hematologie

JF - Nouvelle revue francaise d"hematologie

IS - 1

ER -